Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 47051-47100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05329285
CABG or PCI in Patients With Ischemic Cardiomyopathy
NARecruiting
470 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2052
1 condition4 sponsors1 location
NCT05729399
Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 14, 2022 · Completed: May 1, 2025
1 condition1 sponsor4 locations
NCT05433636
Mindful Waiting Room
NARecruiting
305 participants
Started: Sep 14, 2022 · Completed: Dec 1, 2024
6 conditions1 sponsor1 location
NCT05300893
Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture
NARecruiting
154 participants
Started: Sep 14, 2022 · Completed: Jan 31, 2027
2 conditions1 sponsor3 locations
NCT05384821
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
PHASE1/PHASE2Recruiting
28 participants
Started: Sep 14, 2022 · Completed: Oct 31, 2028
1 condition1 sponsor18 locations
NCT05562323
Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study
N/ARecruiting
100 participants
Started: Sep 14, 2022 · Completed: Aug 31, 2026
1 condition3 sponsors3 locations
NCT05541406
Efficacy of a Multi-level School Intervention for LGBTQ Youth
NARecruiting
450 participants
Started: Sep 14, 2022 · Completed: Dec 1, 2025
9 conditions3 sponsors21 locations
NCT05344612
Comparing a Diagnostic and Treatment Strategy of Upfront CTCA With SOC in Patients With Chest Pain and Suspected CAD
NARecruiting
6,444 participants
Started: Sep 14, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT05170399
Vaccine Responses in Patients With B Cell Malignancies
PHASE4Recruiting
500 participants
Started: Sep 14, 2022 · Completed: Aug 16, 2026
1 condition1 sponsor1 location
NCT05360290
CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial
NARecruiting
484 participants
Started: Sep 14, 2022 · Completed: Jun 30, 2029
2 conditions1 sponsor1 location
NCT05288361
The DISCOVER INOCA Prospective Multi-center Registry
N/ARecruiting
500 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2032
6 conditions2 sponsors9 locations
NCT05147909
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
NARecruiting
124 participants
Started: Sep 14, 2022 · Completed: Mar 30, 2028
3 conditions1 sponsor1 location
NCT05547529
The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer
PHASE3Recruiting
156 participants
Started: Sep 14, 2022 · Completed: Sep 14, 2027
1 condition1 sponsor1 location
NCT05465941
PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
PHASE2Recruiting
43 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2031
6 conditions2 sponsors1 location
NCT05625971
Non-invasive MRD Assessment in Multiple Myeloma
N/ARecruiting
88 participants
Started: Sep 14, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT06547515
Bone and Muscle Health Following Sleeve Gastrectomy in Men, Premenopausal and Postmenopausal Women
N/ARecruiting
156 participants
Started: Sep 14, 2022 · Completed: Aug 15, 2026
4 conditions2 sponsors1 location
NCT06082687
De-identified Human Tissue Project
N/ARecruiting
1,000,000 participants
Started: Sep 14, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05172765
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
NARecruiting
160 participants
Started: Sep 14, 2022 · Completed: May 29, 2026
1 condition1 sponsor1 location
NCT05519384
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia
EARLY_PHASE1Recruiting
12 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05761067
STICH-3.0 International Trial Consortium
NARecruiting
2,800 participants
Started: Sep 14, 2022 · Completed: Sep 14, 2029
2 conditions14 sponsors1 location
NCT05489887
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
PHASE2Recruiting
93 participants
Started: Sep 14, 2022 · Completed: Sep 30, 2036
1 condition2 sponsors23 locations
NCT05522972
Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
NARecruiting
180 participants
Started: Sep 13, 2022 · Completed: Aug 31, 2029
1 condition1 sponsor1 location
NCT05467891
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
PHASE2Recruiting
200 participants
Started: Sep 13, 2022 · Completed: Aug 31, 2029
3 conditions2 sponsors18 locations
NCT04796545
Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration
NARecruiting
76 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2028
2 conditions1 sponsor8 locations
NCT05554588
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
NARecruiting
2,500 participants
Started: Sep 13, 2022 · Completed: Sep 1, 2026
3 conditions1 sponsor1 location
NCT05401097
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
PHASE2Recruiting
125 participants
Started: Sep 13, 2022 · Completed: Jun 30, 2029
1 condition2 sponsors1 location
NCT06581887
Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies
N/ARecruiting
100 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05537467
Effect of Music on Cardiopulmonary Exercise Capacity in Heart Failure Patients
NARecruiting
40 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05336812
Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia
PHASE2Recruiting
52 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05435014
T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
90 participants
Started: Sep 13, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor4 locations
NCT05512481
Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma
PHASE2Recruiting
60 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2026
7 conditions1 sponsor1 location
NCT05480800
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
PHASE1/PHASE2Recruiting
155 participants
Started: Sep 13, 2022 · Completed: Dec 18, 2024
1 condition5 sponsors2 locations
NCT05335070
Reducing Pain From Wisdom Molar Extractions
PHASE2Recruiting
20 participants
Started: Sep 13, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05081245
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
PHASE2Recruiting
150 participants
Started: Sep 13, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor41 locations
NCT05708885
Striated Esophageal Motor Function Modulation in Health and Disease
NARecruiting
557 participants
Started: Sep 13, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT07103161
Managing Impact-related Leakage During Exercise Using Intravaginal Support
NARecruiting
30 participants
Started: Sep 13, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05452005
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
PHASE1Recruiting
20 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05338151
Promoting Alcohol Treatment Engagement Post-hospitalization
NARecruiting
450 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04628026
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
PHASE3Recruiting
650 participants
Started: Sep 13, 2022 · Completed: Feb 29, 2032
1 condition2 sponsors90 locations
NCT05536505
Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
PHASE2Recruiting
180 participants
Started: Sep 13, 2022 · Completed: Oct 1, 2030
1 condition1 sponsor16 locations
NCT04515459
Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma
PHASE2Recruiting
53 participants
Started: Sep 13, 2022 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT05369273
Addition of Platelet Rich Plasma (PRP) in Microfat Lipofilling (MG) in the Treatment of Cranial Flap Scars: A Randomized, Double-blind, Superiority Study
NARecruiting
22 participants
Started: Sep 13, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05009082
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
PHASE3Recruiting
970 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2031
3 conditions2 sponsors65 locations
NCT05531565
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
PHASE2/PHASE3Recruiting
474 participants
Started: Sep 13, 2022 · Completed: Dec 14, 2027
2 conditions1 sponsor263 locations
NCT05511285
Improving Sleep and Learning in Rehabilitation After Stroke, Part 2
NARecruiting
100 participants
Started: Sep 13, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05255601
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
PHASE1/PHASE2Recruiting
68 participants
Started: Sep 13, 2022 · Completed: Jul 5, 2028
2 conditions1 sponsor76 locations
NCT05519696
Together Everyone Achieves More (TEAM) Trial
NARecruiting
360 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05026541
Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators
NARecruiting
60 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05517668
Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose
PHASE2Recruiting
40 participants
Started: Sep 12, 2022 · Completed: Nov 30, 2025
7 conditions2 sponsors1 location
NCT05308264
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
PHASE1/PHASE2Recruiting
86 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations